ACTINIUM PHARMACEUTICALS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/15d4ddbd-940d-4011-91d9-bf31f4e7c996/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $90.0k | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-036504 |
| FY 2023 | $81.0k | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-028038 |
| FY 2022 | $1.0M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-025597 |
| FY 2021 | $1.1M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-015208 |
| FY 2011 | $0 | 2011-01-01 – 2011-12-31 | evidence 0001078782-12-001008 |
| FY 2010 | $0 | 2010-01-01 – 2010-12-31 | evidence 0001078782-12-001008 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACTINIUM PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income